a public good project by the
Synthesis
Company
of California

© 2026

Ventzislava Petrov–Sanchez | doi.page

0 works0 citations0 h-index

Ventzislava Petrov–Sanchez

Université de Bordeaux(FR)Inserm(FR)Université Paris-Saclay(FR)Montreal Heart Institute(CA)Assistance Publique – Hôpitaux de Paris(FR)Bordeaux Population Health(FR)Bicêtre Hospital(FR)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatitis C virus research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies

Most-Cited Works

→ Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890(2013)431 cited
→ Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis(2014)259 cited
→ Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation(2015)133 cited
→ Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients(2016)127 cited
→ The negative impact of HBV/HCV coinfection on cirrhosis and its consequences(2017)89 cited
→ Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives(2020)76 cited

→ Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2(2022)66 cited

→ Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019(2021)40 cited

→ Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults(2022)38 cited

→ Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death(2020)35 cited